Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2015 16:05 ET | Source: Dermira, Inc.

Dermira to Present at the 2015 Leerink Global Healthcare Conference

MENLO PARK, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
January 08, 2015 02:00 ET | Source: Dermira, Inc.

Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis

Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis Program includes the first Phase 3 study in psoriasis comparing two...
December 22, 2014 08:00 ET | Source: Dermira, Inc.

Dermira Added to Russell 2000(R) Index

MENLO PARK, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...
November 12, 2014 16:05 ET | Source: Dermira, Inc.

Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology...
October 02, 2014 21:37 ET | Source: Dermira, Inc.

Dermira Prices Initial Public Offering

REDWOOD CITY, Calif., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...